Skip to main content

Articles

Are We Winning the War on Drugs?
Read More
Assessing Abuse-Deterrent Formulations: Much Work Still Remains
Read More
In Vitro and Clinical Assessments of Abuse-Deterrent Formulations for Chronic Pain
Read More
Clinical Assessment of Abuse-Deterrent Formulations
Read More
The Tip of the Iceberg
Read More
In Vitro and Clinical Assessments of Abuse-Deterrent Formulations in the Management of Chronic Pain
Read More
Conference Highlights ASH
Improving the Standard of Care
Read More
Perspectives
PEACE Time
Read More
Letters to the Editor
Correspondence: Cost of Treatment for Relapsed/Refractory Multiple Myeloma
Read More
Original Research, Practice Management
Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors
Stakeholder Perspective
Generic Imatinib: Can It Provide Significant Cost Relief for Patients?
Read More
Page 121 of 244
Results 1201 - 1210 of 2434